In the systemic review, Arts-de Jong et al. reported a 6.2% mean probability of finding a germline BRCA1/2 mutation in a patient with ovarian cancer and without a positive family history for breast and/or ovarian cancer [24]. Here, BRCA1 is linked to ovarian cancer.